ERAS versus standard perioperative care for parent-infant bonding after cesarean delivery
Official title: The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.
Run by Okan University · NCT07276126 · Data updated 2026-11-12
This trial will test whether using the ERAS protocol after cesarean helps mothers and fathers bond with their newborns compared with standard perioperative care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 1 (estimated) |
| Sponsor | Okan University Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | December 13, 2025 |
| Main results expected | February 20, 2026 |
| Study ends | April 20, 2026 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT07276126 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Turkish-speaking pregnant women aged 18–60 with a singleton, term (≥37 weeks) pregnancy undergoing elective or indicated cesarean delivery whose partners are willing to complete postpartum questionnaires.
✕Probably not a fit
Patients with preterm birth, major neonatal complications requiring prolonged NICU care, severe maternal obstetric complications (e.g., massive hemorrhage, hysterectomy, severe preeclampsia/eclampsia), active severe psychiatric disorder, or inability to complete Turkish questionnaires are unlikely to benefit from the study intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel-group trial compares an Enhanced Recovery After Surgery (ERAS) protocol to standard perioperative care for women undergoing cesarean delivery, starting at Istanbul Okan University Hospital and expanding to additional centers after site preparation. Participants are randomized 1:1 to ERAS—which includes preoperative education, multimodal analgesia, early oral intake, early mobilization, and early catheter removal—or to usual care, and fathers are invited to participate in bonding assessments. The primary outcome is mother-infant bonding measured by the Postpartum Bonding Questionnaire (PBQ) on postpartum day 7, with secondary outcomes including early attachment scales and Edinburgh Postnatal Depression Scale scores at 2 hours, 24 hours, day 4, and day 7. The design aims to capture early psychosocial effects of perioperative pathways on both maternal and paternal bonding.
Why it matters
Potential benefit: If successful, ERAS could improve early mother-infant and father-infant bonding while supporting faster physical recovery and potentially lowering postpartum mood problems.
How similar studies have gone: ERAS has documented benefits for physical recovery and reduced opioid use in obstetrics in pilot and observational reports, but randomized evidence showing improved parent-infant bonding is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
IInclusion Criteria: Pregnant women aged 18-60 years. Singleton, live fetus, and ≥37 weeks of gestation. Undergoing elective or medically indicated cesarean delivery. Ability to read and understand Turkish (for questionnaire validity). Mothers and fathers willing and able to complete postpartum follow-up assessments (2 hours, 24 hours, day 4, day 7). Provision of written informed consent by mother and, if participating, by father/partner. Maternal postpartum clinical stability (no condition precluding questionnaire completion). ❌ Exclusion Criteria (Dışlanma Kriterleri) Exclusion Criteria: Preterm birth (\<37 weeks) or multiple gestation (twins, triplets). Stillbirth, early neonatal death, or major congenital anomaly. Newborn requiring prolonged NICU stay preventing bonding assessments. Maternal severe obstetric complications: Massive postpartum hemorrhage Hysterectomy Severe preeclampsia or eclampsia Severe postpartum infection Maternal active psychiatric disorder or use of psychotropic medication. Maternal need for high-dose opioid analgesia or sedation interfering with bonding assessments. Inability to read/understand Turkish or cognitive impairment preventing questionnaire completion. Failure to complete follow-up visits (2 hours, 24 hours, day 4, day 7). Withdrawal of consent at any time.
Where it's running
-
Istanbul Okan University Hospital
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Gökçenur Karakelleoğlu, Assist Prof
- Email: gokcenur.karakelleoglu@okan.edu.tr
- Phone: +905326702049
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of massage and exercises on cesarean scar and recovery
This study tests whether direct scar massage or indirect massage plus exercise helps people recover after a cesarean birth and reduces scar-related pain.
-
Reflexology and hand massage after cesarean section
This study tests whether reflexology hand massage or stroking hand massage can reduce anxiety and increase satisfaction, and how they affect heart/blood pressure after cesarean delivery.
-
Health education to see if primigravida women choose vaginal delivery more often
A health education program is being tested to see if it helps first-time pregnant women in choosing vaginal delivery over unnecessary cesareans.
-
Enhanced Recovery Adherence and Recovery Quality After Cesarean Delivery
This study tests whether following enhanced recovery after cesarean delivery protocols is linked with better recovery quality in women having a planned cesarean with spinal anesthesia.
-
Predictors of severe pain within 24 hours after cesarean delivery with spinal anesthesia
This study will look at which pre-, intra-, and post-operative factors are linked to severe pain in the first 24 hours after an elective cesarean done with spinal anesthesia.
-
Enhanced Recovery After Surgery for Gynecologic Procedures
This study tests whether an ERAS program can help women undergoing gynecologic surgery recover faster compared with traditional perioperative care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.